secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0001213900-21-057950
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx Q3 revenue up 53% to $16.1M; GAAP net income $0.04M
--------------------------------------------------------------

- Revenue $16.1M (+53% YoY); brands on platform increased to 182 from 140.
- GAAP net income $0.04M ($0.00 EPS) vs loss of $0.3M YoY; non-GAAP net income $1.6M ($0.09 EPS).
- Gross margin 56.3% (slight decrease from 57.2%); cash $85M.
- RWE solution gaining traction; average client ROI 13:1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021057950/0001213900-21-057950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021057950/ea150273-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-057950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer